- Home
- SLI vs AVIR Comparison
SLI vs AVIR Comparison
Compare SLI & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SLI | AVIR |
|---|---|---|
| Founded | 1998 | 2012 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 524.3M | 413.1M |
| IPO Year | 2011 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SLI | AVIR |
|---|---|---|
| Price | $1.45 | $4.04 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 3 |
| Target Price | $4.49 | ★ $9.42 |
| AVG Volume (30 Days) | ★ 2.1M | 276.1K |
| Earning Date | 08-10-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $351,367,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.32 | $2.87 |
| 52 Week High | $6.00 | $6.45 |
Technical Indicators
Market Signals| Indicator | SLI | AVIR |
|---|---|---|
| Relative Strength Index (RSI) | 28.27 | 25.19 |
| Support Level | $1.32 | $3.34 |
| Resistance Level | $2.25 | $4.46 |
| Average True Range (ATR) | 0.08 | 0.24 |
| MACD | 0.02 | -0.09 |
| Stochastic Oscillator | 30.49 | 8.46 |
Price Performance
Historical ComparisonAbout SLI Standard Lithium Ltd.
Standard Lithium Corp is engaged in the exploration and development of lithium brine properties in the United States. The company's flagship projects are located in the Smackover Formation, a world-class lithium brine asset, focused in Arkansas and Texas. It is also Standard Lithium is advancing the South West Arkansas project, a greenfield project located in southern Arkansas, and strengthening lithium brine prospects in East Texas. Its other project comprises the Lanxess Property Project; and California Properties. The technologies used for the projects are : Direct Lithium Extraction; Demonstration Plant; SiFT; Lithium Sulfide; and Aqualung.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.